Literature DB >> 10382740

TWEAK can induce cell death via endogenous TNF and TNF receptor 1.

P Schneider1, R Schwenzer, E Haas, F Mühlenbeck, G Schubert, P Scheurich, J Tschopp, H Wajant.   

Abstract

TWEAK is a recently cloned novel member of the TNF ligand family. Here we show that soluble TWEAK is sufficient to induce apoptosis in Kym-1 cells within 18 h. TWEAK-induced apoptosis is indirect and is mediated by the interaction of endogenous TNF and TNF receptor (TNFR)1, as each TNFR1-Fc, neutralizing TNF-specific antibodies and TNFR1-specific Fab fragments efficiently antagonize cell death induction. In addition to this indirect mode of action, co-stimulation of Kym-1 cells with TWEAK enhances TNFR1-mediated cell death induction. In contrast to TNF, TWEAK does only modestly activate NF-kappaB or c-jun N-terminal kinase (JNK) in Kym-1 cells. Although TWEAK binding to Kym-1 cells is easily detectable by flow cytometric analysis, we found neither evidence for expression of the recently identified TWEAK receptor Apo3/TRAMP/wsl/DR3/LARD, nor indications for direct interactions of TWEAK with TNFR. Together, these characteristics of TWEAK-induced signaling in Kym-1 cells argue for the existence of an additional, still undefined non-death domain-containing TWEAK receptor in Kym-1 cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10382740     DOI: 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  48 in total

1.  IAPs, TNF, inflammation and Jürg Tschopp; a personal perspective.

Authors:  J Silke; J E Vince
Journal:  Cell Death Differ       Date:  2012-01       Impact factor: 15.828

2.  TWEAK induces liver progenitor cell proliferation.

Authors:  Aniela Jakubowski; Christine Ambrose; Michael Parr; John M Lincecum; Monica Z Wang; Timothy S Zheng; Beth Browning; Jennifer S Michaelson; Manfred Baetscher; Manfred Baestcher; Bruce Wang; D Montgomery Bissell; Linda C Burkly
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

Review 3.  The TWEAK-Fn14 system as a potential drug target.

Authors:  Harald Wajant
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

4.  Tumor necrosis factor (TNF) signaling, but not TWEAK (TNF-like weak inducer of apoptosis)-triggered cIAP1 (cellular inhibitor of apoptosis protein 1) degradation, requires cIAP1 RING dimerization and E2 binding.

Authors:  Rebecca Feltham; Maryline Moulin; James E Vince; Peter D Mace; Wendy Wei-Lynn Wong; Holly Anderton; Catherine L Day; David L Vaux; John Silke
Journal:  J Biol Chem       Date:  2010-03-30       Impact factor: 5.157

5.  Low blood levels of sTWEAK are related to locoregional failure in head and neck cancer.

Authors:  Francesc Xavier Avilés-Jurado; Ximena Terra; David Gómez; Joan Carles Flores; Antoni Raventós; Elsa Maymó-Masip; Xavier León; Vicente Serrano-Gonzalvo; Joan Vendrell; Enric Figuerola; Matilde R Chacón
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-05-26       Impact factor: 2.503

6.  Regulation of fibroblast growth factor-inducible 14 (Fn14) expression levels via ligand-independent lysosomal degradation.

Authors:  Sujatha Gurunathan; Jeffrey A Winkles; Sankar Ghosh; Matthew S Hayden
Journal:  J Biol Chem       Date:  2014-03-20       Impact factor: 5.157

7.  Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis.

Authors:  Harshil Dhruv; Joseph C Loftus; Pooja Narang; Joachim L Petit; Maureen Fameree; Julien Burton; Giresse Tchegho; Donald Chow; Holly Yin; Yousef Al-Abed; Michael E Berens; Nhan L Tran; Nathalie Meurice
Journal:  J Biol Chem       Date:  2013-09-20       Impact factor: 5.157

8.  DR3 regulates negative selection during thymocyte development.

Authors:  E C Wang; A Thern; A Denzel; J Kitson; S N Farrow; M J Owen
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

9.  Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activity.

Authors:  Steffen Salzmann; Axel Seher; Johannes Trebing; Daniela Weisenberger; Alevtina Rosenthal; Daniela Siegmund; Harald Wajant
Journal:  J Biol Chem       Date:  2013-03-26       Impact factor: 5.157

Review 10.  TWEAK and the central nervous system.

Authors:  Manuel Yepes
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.